Colour contrast sensitivity (CCS) of a large cohort ofglaucomatous patients, ocular hypertensive patients (OH), and normal persons was measured at six-month intervals during a twoyear period. The OHs were graded into high, medium, and low risk groups. 69%o of glaucomatous patients and 32% of all OHs had CCS thresholds greater than the mean plus 2 SDs of the controls. Satisfactory specificity and sensitivity could not be obtained by adjusting the criterion of threshold. In abnormal eyes, progressive small increases of threshold occurred during the study, but glaucomatous eyes with normal thresholds on the first visit retained normal thresholds in the subsequent visits. Although our system is very sensitive and precise, the proportion of abnormalities detected is no greater than with other techniques. In some glaucomatous patients there is a true preservation of colour vision which does not merely reflect the limitations of the test employed.
Acquired dyschromatopsia can occur early in the course of glaucoma. A blue-yellow loss of colour vision is usually found and may be apparent before nerve fibre bundle defects are detected or visual field defects found.' In addition it has been shown that some eyes with ocular hypertension (OH) also have a similar defect.23 Drance4 reported a colour vision loss in 20% of cases of OH and suggested that testing colour vision could help to identify those who are likely to develop glaucoma. However, some glaucoma patients never show abnormal colour vision, and conversely some OH patients who have abnormal colour vision never develop glaucoma. 4 These discrepancies might either reflect limitations in testing techniques or the complex relation between mechanisms of loss of colour vision and the increase in intraocular pressure (IOP) . In principle a distinction could be made between these classes of hypothesis if a more sensitive test of colour vision were to be available.
Colour vision techniques used in clinical practice include the Ishihara test, AO pseudoisochromatic plates, 100-hue Farnsworth and its derivatives, and the anomaloscope5 (for a review see Hart'0) . Another technique which has been used to assess colour vision changes, especially in patients with glaucoma, is colour perimetry." ' The value of testing colour vision depends on the sensitivity and specificity of the test, and this is shown in Fig 2 for the tritan threshold. The discrimination obtained between normal and glaucomatous eyes varied with the colour contrast, which is considered to be abnormal. Fig 4) , there was during the investigation a progressive loss of sensitivity in glaucoma patients, whose mean threshold increased by 2% between the first and second visit and by >1% between the second and the third. The tritan thresholds for all visits are shown in Table 2 . Since patients were recruited during the. period of the investigation, the number of eyes progressively decreased with visit number, which precludes comparison between columns. (Fig 4) . Thus the test-retest variation contributed almost nothing to the variability of the results.
The mean threshold of all eyes in each visit ( (Fig 1) . With 8% taken as a cut-off 43% of low risk would be considered abnormal. The measurements of tritan thresholds for all visits are given in Table 2 . Variation of mean thresholds ofeyes seen on three visits (n = 34) was within 1% (Table 2) 
